联合抗逆转录病毒疗法 （ART） 对 人类免疫缺陷病毒（HIV）和慢性乙型肝炎病毒 （HBV） 共感染成人患者的肝纤维化模式的长期影响尚不清楚。中山大学联合首都医科大学对此进行了研究，近期发表于Virologica ...

编者按：人类免疫缺陷病毒（HIV）与乙型肝炎病毒（HBV）共感染是一种全球性公共卫生问题，全球约有10%的HIV感染者同时感染HBV，特别是在高风险地区，如非洲和亚洲，这一比例可能更高。在2025年反转录病毒和机会性感染大会（CROI ...

HBV’s morbidity arises in part from its ‘stealth ... including the degree and duration of CD4 T cell and B cell stimulation, could expand immunomodulation strategies. With many unanswered ...

Chronic and persistent HBV infection is associated with weak and functionally impaired immune response. The persistent exposure to viral antigens leads to virus-specific CD4 and CD8 cell ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...